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28S Abstracts May Supplement 2013Our choice is general anesthesia with local inﬁltration.
We no longer perform the classical complete transection
and eversion endarterectomy after gaining experience and
success with our technique.
Results: During the last three years, we selected 100
patients for this procedure. Every patient woke up immedi-
ately from the anesthesia without neurological deﬁcits,
hematomas, nerve injuries or cardiac complications. Overall
the perioperative results are excellent.
Conclusions: This approach is feasible, safe, simple,
and an effective method of intervention for carotid
reconstruction.
Author Disclosures: M. Avila: Nothing to disclose.Table. Incidence of SCI according to extent of
endograft repair
Type of repair No. (%) Incidence of SCI, No. (%)
Total 1251 (100) 36 (2.9)
AAA 351 (28) 1 (0.3)
Juxtarenal AAA 213 (17) 1 (0.5)
TAA 194(16) 10 (5.2)
TAAA 493 (39) 24 (4.9)
SCI, Spinal cord ischemia; AAA, abdominal aortic aneurysm; TAA, thoracic
aortic aneurysm, TAAA, thoracoabdominal aortic aneurysmSS14.
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Objectives: Carotid endarterectomy (CEA) is the
operation vascular surgeons perform most frequently in
the US. Given the resource burden of unplanned readmis-
sions (URA), we sought to identify the predictors/conse-
quences of URA within 30 days (d) of CEA for potential
points of intervention.
Methods: Retrospective analysis of consecutive CEAs
(2001-2011) at a single institution. Primary endpoint was
URA within 30d. Factors crudely associated with URA at
P < .05 were included in the stepwise multivariable anal-
ysis. Death through 1 year was compared with the log
rank test for the Kaplan-Meier estimator.
Results: 840 patients underwent 896 CEAs. Median
postop LOS was 1 day (interquartile range [IQR], 1-2).
Overall 30d readmission rate was 8.6% and URA rate was
6.5%. The most frequent reasons for URA were cardiac,
other medical complications and headache. Nearly half of
the URA patients (27, 46.5%) were readmitted for
a CEA-related reason (headache, cardiac, hypertension,
wound infection, bleeding/hematoma, stroke/TIA,
dysphagia, hyperperfusion syndrome). 16 (27.5%) patients
had more than one reason for URA. Median time to
URA was 4d (IQR 1-9). Unadjusted risk factors for URA
were history of CAD, CABG, or CHF and postop in-
hospital occurrence of stroke, bleeding/hematoma, myocar-
dial infarction or CHF. Hospital LOS, indication for CEA
and discharge destination were not associated with URA.
In multivariable analysis, prior CABG (adjusted odds ratio
[OR], 2.2, 95% CI, 1.2-3.9; P ¼ .009) and postop in-
hospital stroke(OR, 7.1, 95% CI, 2.0-25.1; P ¼ .003),
bleeding/hematoma (OR, 3.3; 95% CI, 1.4-8.2; P ¼
.009) and CHF (OR, 55.2, 95% CI, 5.5-52.5; P ¼ .006)
were signiﬁcantly associated with URA. URA was associated
with increased mortality over 1 year (log rank test, P ¼ .02).
Conclusions: The 30-day URA rate after CEA is low
(6.5%). Prior CABG and in-hospital postop occurrence of
stroke, bleeding/hematoma and CHF identify those atincreased risk of URA. URA may signal increased long-
term risk of postoperative mortality.
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Objectives: This study evaluated factors affecting
outcomes from SCI associated with endovascular aortic
aneurysm repair.
Methods: 1251 patients enrolled in an IDE endograft
trial (1998-2010) were screened for SCI. A records review
supplemented prospective outcomes data. Demographics,
collateral bed (hypogastric (HA) and subclavian (SA)
artery) patency, presentation, and outcomes were evaluated
on patients with SCI.
Results: SCI occurred in 2.9% (Table) of patients.
Among SCI patients, SA bypass was performed in four
(13%) patients, and two had intraoperative SA coverage.
Preoperative HA occlusion was present in 14 (31%), and
an additional seven had intraoperative HA occlusion. SCI
was immediately apparent in 15 (42%) patients. The pres-
ence of an occluded SA or HA increased the risk of imme-
diate onset of SCI symptoms compared to those with
patent collaterals (73% vs 24%; P ¼ .021). Of those pre-
senting in a delayed fashion, nine (43%) had a clear precip-
itating event prior to SCI onset. Recovery occurred in 24
(67%) patients. Immediate onset was a negative predictor
of recovery (P ¼ .025), as was occlusion of a single collat-
eral bed (P ¼ .035). Mean follow up was 22 6 4 months,
with 30-day and 1-year survival of 92 6 4.6% and 56 6
8.3%. Survival at 3 months was lower in those that did
not recover from SCI symptoms (36% v. 92%; P < .001).
Conclusions: Single collateral bed occlusion predicts
immediate onset SCI and lack of recovery, which portends
increased mortality. Collateral bed preservation may limit
this complication following endovascular AA repair.
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Objectives: The impact of postoperative troponin
elevation on long-term survival after vascular surgery is
not well deﬁned. We hypothesize that a troponin elevation
is associated with reduced long-term survival.
Methods: The VSGNE identiﬁed all patients who
underwent carotid revascularization, open AAA repair,
endovascular AAA repair, or infrainguinal lower extremity
bypass (2003-2011). The effect of postoperative troponinelevation and myocardial infarction (MI) on 5 year survival
was evaluated using Kaplan Meier analysis and Cox Propor-
tional Hazards models.
Results: In 16,363 patients, the incidence of postop-
erative troponin elevation and MI were 1.3% (n ¼ 211)
and 1.6%(n ¼ 264), respectively. Both were associated
with reduced 5 year survival: no ischemia, 73%; troponin
elevation, 54%; MI, 33% (P < .0001). This pattern was
observed for each procedure subgroup analysis (P <
.0001). Troponin elevation (HR, 1.45; 95% CI, 1.1-2.0;
P ¼ .02) and MI (HR, 2.9; 95% CI, 2.3-3.8; P <
.0001) were independent predictors of reduced 5 year
survival.
Conclusions: Postoperative troponin elevation and
MI predict 26% and 55% lower 5 year survival, respectively,
after vascular procedures compared with no myocardial
ischemia. This highlights the need to better characterize
factors leading to postoperative myocardial ischemia. Post-
operative troponin elevation alone is a marker for high-risk
patients who might beneﬁt from more aggressive cardiac
optimization.
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